This inventor holds 2 USPTO granted patents. Top assignee: Other. Active years: 2007-2011.
Location History:
- Calgary, CA (2007)
- Alberta, CA (2011)
Company Filing History:
2 out of 834,411 Years Active: 2007-2011
Title: Innovations by Seungjin Shin in Diabetes Treatment
Introduction
Seungjin Shin is an accomplished inventor based in California, known for his significant contributions to the field of diabetes treatment. With a focus on developing innovative cell lines that can effectively manage insulin secretion, he has made strides in addressing the challenges faced by individuals with diabetes. His work has led to the filing of 2 patents that showcase his expertise and dedication to medical advancements.
Latest Patents
Seungjin Shin's latest patents include groundbreaking inventions aimed at improving diabetes treatment. One of his notable patents is the "Immortalized hepatocyte cell line secreting modified insulin with glucose sensitivity." This invention provides a cell line that can substitute for β cells in human mature pancreatic islets, expressing insulin in a glucose-concentration dependent manner. This innovation enables the easy obtainment of the number of cells required to meet demand and offers a therapeutical cell preparation for treating diabetes. The cell lines can be obtained by integrating a nucleotide sequence encoding tamoxifen-induced Cre recombinase and a nucleotide sequence encoding insulin regulated by a glucose-sensitive promoter into a human immortalized hepatic cell line.
Another significant patent is the "Insulin-secreting immortalized liver cell line modified by glucose sensitivity." Similar to his previous invention, this patent also provides a cell line that can replace β cells and express insulin based on glucose concentration. This advancement further enhances the potential for therapeutic applications in diabetes treatment.
Career Highlights
Throughout his career, Seungjin Shin has demonstrated a commitment to innovation in the medical field. His work has not only contributed to scientific knowledge but has also paved the way for new therapeutic options for diabetes management. His patents reflect a deep understanding of cellular biology and the mechanisms of insulin regulation.
Collaborations
Seungjin Shin has collaborated with notable professionals in his field, including Hee-Sook Jun and Naoya Kobayashi. These collaborations have fostered a productive environment for research and development, leading to significant advancements in diabetes treatment.
Conclusion
Seungjin Shin's innovative work in developing insulin-secreting cell lines represents a promising advancement in diabetes treatment. His patents highlight the potential for new therapeutic approaches that could significantly improve the quality of life for individuals living with diabetes.